These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 33849356)

  • 1. Severe hand sanitiser (isopropanol) toxicity managed with continuous venovenous haemodiafiltration and angiotensin II.
    Chieng S; Malouf S; Costa-Pinto R; Bellomo R; Gerostamoulos D; Wong A
    Clin Toxicol (Phila); 2021 Dec; 59(12):1277-1278. PubMed ID: 33849356
    [No Abstract]   [Full Text] [Related]  

  • 2. Dialyzability of lamotrigine by continuous venovenous haemodiafiltration.
    Premachandra K; Priyadarshini S; Roberts D
    Clin Toxicol (Phila); 2022 Feb; 60(2):267. PubMed ID: 33945365
    [No Abstract]   [Full Text] [Related]  

  • 3. Continuous Renal Replacement Therapy: Who, When, Why, and How.
    Tandukar S; Palevsky PM
    Chest; 2019 Mar; 155(3):626-638. PubMed ID: 30266628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous haemofiltration and haemodiafiltration for acute renal failure in severely burned patients.
    Leblanc M; Thibeault Y; Quérin S
    Burns; 1997 Mar; 23(2):160-5. PubMed ID: 9177886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replacement and dialysate fluids for patients with acute renal failure treated by continuous veno-venous haemofiltration and/or haemodiafiltration.
    Davenport A
    Contrib Nephrol; 2004; 144():317-28. PubMed ID: 15264420
    [No Abstract]   [Full Text] [Related]  

  • 6. A prospective study of continuous venovenous hemodiafiltration in critically ill patients with acute renal failure.
    Bellomo R; Farmer M; Boyce N
    J Intensive Care Med; 1995; 10(4):187-92. PubMed ID: 10155183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Double-Blind Randomized Controlled Trial of High Cutoff Versus Standard Hemofiltration in Critically Ill Patients With Acute Kidney Injury.
    Atan R; Peck L; Prowle J; Licari E; Eastwood GM; Storr M; Goehl H; Bellomo R
    Crit Care Med; 2018 Oct; 46(10):e988-e994. PubMed ID: 30074491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure.
    Bellomo R; McGrath B; Boyce N
    Crit Care Med; 1994 May; 22(5):833-7. PubMed ID: 8181293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous venovenous hemofiltration versus continuous venovenous hemodiafiltration in critically ill patients: a retrospective cohort study from a Canadian tertiary centre.
    AlEnezi F; Alhazzani W; Ma J; Alanazi S; Salib M; Attia M; Thabane L; Fox-Robichaud A
    Can Respir J; 2014; 21(3):176-80. PubMed ID: 24712012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe COVID-19 in a patient with chronic kidney disease: Is there a positive effect of continuous venovenous hemodiafiltration?
    Xing X; Yang Y; Shi J; Cheng A; Wang Y; Xu G; He F
    Nefrologia (Engl Ed); 2021; 41(4):478-480. PubMed ID: 36165120
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Net Ultrafiltration Rate With Mortality Among Critically Ill Adults With Acute Kidney Injury Receiving Continuous Venovenous Hemodiafiltration: A Secondary Analysis of the Randomized Evaluation of Normal vs Augmented Level (RENAL) of Renal Replacement Therapy Trial.
    Murugan R; Kerti SJ; Chang CH; Gallagher M; Clermont G; Palevsky PM; Kellum JA; Bellomo R
    JAMA Netw Open; 2019 Jun; 2(6):e195418. PubMed ID: 31173127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous Venovenous Hemofiltration in Children Less Than or Equal to 10 kg: A Single-Center Experience.
    Kaempfen S; Dutta-Kukreja P; Mok Q
    Pediatr Crit Care Med; 2017 Feb; 18(2):e70-e76. PubMed ID: 27977538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.
    Leblanc M; Garred LJ; Cardinal J; Pichette V; Nolin L; Ouimet D; Geadah D
    Am J Kidney Dis; 1998 Sep; 32(3):444-53. PubMed ID: 9740161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of meropenem during continuous veno-venous haemofiltration and haemodiafiltration in patients with acute renal failure.
    Valtonen M; Tiula E; Backman JT; Neuvonen PJ
    J Antimicrob Chemother; 2000 May; 45(5):701-4. PubMed ID: 10797097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
    Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
    Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of meropenem in intensive care unit patients receiving continuous veno-venous hemofiltration or hemodiafiltration.
    Giles LJ; Jennings AC; Thomson AH; Creed G; Beale RJ; McLuckie A
    Crit Care Med; 2000 Mar; 28(3):632-7. PubMed ID: 10752806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Commercially Available Warming Device to Achieve Normothermia During Continuous Venovenous Hemofiltration in Patients Undergoing Orthotopic Liver Transplant.
    Werthman AM; Hass JA; Woehlck HJ; Pagel PS; Boettcher BT
    J Cardiothorac Vasc Anesth; 2022 Jan; 36(1):346-347. PubMed ID: 34244024
    [No Abstract]   [Full Text] [Related]  

  • 18. A Loading Micafungin Dose in Critically Ill Patients Undergoing Continuous Venovenous Hemofiltration or Continuous Venovenous Hemodiafiltration: A Population Pharmacokinetic Analysis.
    Garbez N; Mbatchi LC; Maseda E; Luque S; Grau S; Wallis SC; Muller L; Lipman J; Roberts JA; Lefrant JY; Roger C
    Ther Drug Monit; 2021 Dec; 43(6):747-755. PubMed ID: 33560097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
    Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
    Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19.
    Hanna RM; Ferrey A; Rhee CM; Sam R; Pearce D; Kalantar-Zadeh K; Don BR
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):93-96. PubMed ID: 33186219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.